Saturday, July 3, 2021

Scientists warn of Guillain-Barre syndrome paralysis after Covid-19 vaccination

A few key points:

The AstraZeneca vaccine is not being given in the U.S.

A case of Guillain-Barre has also been identified in a patient who got the Pfizer vaccine. 
In India, there are reports of seven severe cases of Guillain-Barré syndrome 10 to 14 days after the first dose of AstraZeneca's vaccine.

Six were women, all had facial paralysis, "all progressed to quadriplegia, and six required respiratory support. Patients' ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement."

Guillain-Barre syndrome has been reported after other vaccinations. The cause is believed to be damage to the immune system. The disorder can be extremely serious and can lead to total paralysis with dependence on artificial respiration. Even those who recover may have serious muscle wasting and may have to slowly teach the body to relearn most every normal task, such as walking. One in 20 cases is fatal.

 

No comments:

Post a Comment